Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Smith & Nephew SNATS, Inc. (SNN : NYSE)
 
 • Company Description   
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Number of Employees: 18,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $31.98 Daily Weekly Monthly
20 Day Moving Average: 810,150 shares
Shares Outstanding: 435.95 (millions)
Market Capitalization: $13,941.74 (millions)
Beta: 0.62
52 Week High: $44.47
52 Week Low: $29.40
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.13% 6.84%
12 Week -6.65% 2.61%
Year To Date -7.63% 11.35%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING 5 CROXLEY PARK HATTERS LANE
-
WATFORD,X0 WD18 8YE
GBR
ph: 44-19-2347-7100
fax: 44-20-7930-3353
investorrelations.global@smith-nephew.com http://www.smith-nephew.com
 
 • General Corporate Information   
Officers
Roland Diggelmann - Chief Executive Officer
Roberto Quarta - Chairman
Anne-Francoise Nesmes - Chief Financial Officer
Vinita Bali - Director
Ian Barlow - Director

Peer Information
Smith & Nephew SNATS, Inc. (BJCT)
Smith & Nephew SNATS, Inc. (CADMQ)
Smith & Nephew SNATS, Inc. (APNO)
Smith & Nephew SNATS, Inc. (UPDC)
Smith & Nephew SNATS, Inc. (IMTIQ)
Smith & Nephew SNATS, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 83175M205
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 435.95
Most Recent Split Date: 10.00 (2.50:1)
Beta: 0.62
Market Capitalization: $13,941.74 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.83%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.90
Current Fiscal Year EPS Consensus Estimate: $1.73 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 8.29% Last Dividend Paid: 03/31/2022 - $0.45
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.49
Trailing 12 Months: -
PEG Ratio: 2.23
Price Ratios
Price/Book: 2.53
Price/Cash Flow: 11.02
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 2.08
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 1.21
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - 11.24
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 12.66
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 0.86
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.51
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 33.84
09/30/21 - -
 

Powered by Zacks Investment Research ©